Cargando…
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
With a high mortality rate that accounts for millions of cancer-related deaths each year, breast cancer is the second most common malignancy in women. Chemotherapy has significant potential in the prevention and spreading of breast cancer; however, drug resistance often hinders therapy in breast can...
Autores principales: | Singh, Shivam, Saini, Heena, Sharma, Ashok, Gupta, Subhash, Huddar, V. G., Tripathi, Richa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312137/ https://www.ncbi.nlm.nih.gov/pubmed/37397377 http://dx.doi.org/10.3389/fonc.2023.1155254 |
Ejemplares similares
-
Identification of chemoresistance-associated miRNAs in breast cancer
por: Lou, Weiyang, et al.
Publicado: (2018) -
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
Contribution of miRNAs in the Pathogenesis of Breast Cancer
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021) -
Identification of miRNAs contributing to neuroblastoma chemoresistance
por: Ayers, Duncan, et al.
Publicado: (2015) -
An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance
por: Carta, Alessia, et al.
Publicado: (2014)